_2020091018165303jzv.jpg "Decoding The World Of ETF")
My Account
Feb 19, 2021 10:44 AM IST Valuation at a discount to peers, but significant scope for margin improvement
Feb 16, 2021 05:24 PM IST Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated February 11, 2021.
Feb 15, 2021 06:59 PM IST ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1165 in its research report dated February 11, 2021.
Feb 12, 2021 11:06 AM IST In the injectables space, Aurobindo Pharma remains constructive and targets to almost double from current annual sales base of $380 million to $650-700 million in three years backed by new plants in the US and Vizag
Jan 25, 2021 09:35 AM IST We believe dominance of profit/royalty-sharing aspect in the business model distinguishes Gland Pharma from other contract manufacturers
Dec 18, 2020 01:46 PM IST Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1024 in its research report dated December 17, 2020.
Dec 11, 2020 08:32 AM IST Vaccine rollout will throw up opportunities not just for the domestic pharmaceutical and healthcare industry but also the logistics value chain, right from vaccine production, delivery, storage and then the actual immunisation
Nov 18, 2020 01:57 PM IST Prabhudas Lilladher recommended accumulate rating on Aurobindo Pharma with a target price of Rs 921 in its research report dated November 12, 2020.
Nov 17, 2020 11:22 AM IST ICICI Direct is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1025 in its research report dated November 12, 2020.
Nov 15, 2020 11:56 AM IST Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 980 in its research report dated November 12, 2020.
Nov 15, 2020 11:31 AM IST Sharekhan is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1024 in its research report dated November 12, 2020.
Oct 28, 2020 01:19 PM IST Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 985 in its research report dated October 26, 2020.
Oct 27, 2020 02:00 PM IST ICICI Direct is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1025 in its research report dated October 26, 2020.
Sep 28, 2020 11:22 PM IST Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1030 in its research report dated September 27, 2020.
Sep 23, 2020 12:14 PM IST Sharekhan is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 975 in its research report dated September 22, 2020.
Sep 16, 2020 09:40 AM IST Vaccine capacity creation puts Aurobindo in the league of Serum Institute of India and Cadila in the race for a Covid drug
Aug 19, 2020 11:07 AM IST KR Choksey is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1027 in its research report dated August 17, 2020.
Aug 17, 2020 05:06 PM IST Emkay Global Financial is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1000 in its research report dated August 13, 2020.
Aug 16, 2020 09:08 AM IST Prabhudas Lilladher recommended Hold rating on Aurobindo Pharma with a target price of Rs 838 in its research report dated August 13, 2020.
Aug 16, 2020 07:21 AM IST Sharekhan recommended Hold rating on Aurobindo Pharma with a target price of Rs 975 in its research report dated August 13, 2020.
Aug 16, 2020 07:20 AM IST Motilal Oswal is bullish on Aurobindo Pharma recommended buy rating on the stock with a target price of Rs 1055 in its research report dated August 13, 2020.
Aug 14, 2020 12:22 PM IST Aurobindo is building capacities for emerging drug delivery systems in the US and could be a key beneficiary of the localisation initiative there
Aug 14, 2020 12:22 PM IST ICICI Direct is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 1100 in its research report dated August 13, 2020.
Jun 07, 2020 08:50 PM IST Emkay Global Financial is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 835 in its research report dated June 04, 2020.
Jun 07, 2020 08:36 PM IST Motilal Oswal is bullish on Aurobindo Pharma has recommended buy rating on the stock with a target price of Rs 880 in its research report dated June 04, 2020.
